Literature DB >> 32699435

Testing for Down Syndrome in Catholic Health Care: Complicity in Eugenic Abortion.

James G Linn1.   

Abstract

Catholic healthcare institutions, physicians, and midwives routinely employ testing for Down syndrome as a part of prenatal care. This testing is an essential part of eugenic abortion and often leads to it. Catholic teaching clearly forbids such testing when undertaken with abortive intent if the baby has Down syndrome or other abnormalities. This article discusses (1) the evolution of prenatal genetic testing and abortion, (2) how this testing may involve complicity in eugenic abortion, and (3) offers proposals to avoid and end Catholic healthcare's cooperation with this evil.
SUMMARY: This article discusses why prenatal genetic testing as practiced in many Catholic healthcare institutions is ethically problematic and then proposes solutions. © Catholic Medical Association 2019.

Entities:  

Keywords:  Abortion; Bioethics; Catholic identity in health care; Catholic social teaching; Cooperation with evil; Down syndrome; Ethics; Obstetrical care; Prenatal diagnosis; Prenatal genetics/genetic testing in pregnancy

Year:  2019        PMID： 32699435      PMCID： PMC7350118          DOI： 10.1177/0024363919895366

Source DB:  PubMed          Journal:  Linacre Q        ISSN： 0024-3639


  10 in total

1.  First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency.

Authors:  D A Krantz; T W Hallahan; F Orlandi; P Buchanan; J W Larsen; J N Macri
Journal:  Obstet Gynecol       Date:  2000-08       Impact factor: 7.661

Review 2.  Prenatal diagnosis of Down syndrome: a systematic review of termination rates (1995-2011).

Authors:  Jaime L Natoli; Deborah L Ackerman; Suzanne McDermott; Janice G Edwards
Journal:  Prenat Diagn       Date:  2012-02       Impact factor: 3.050

3.  Screening for down syndrome in the United States: results of surveys in 2011 and 2012.

Authors:  Glenn E Palomaki; George J Knight; Edward R Ashwood; Robert G Best; James E Haddow
Journal:  Arch Pathol Lab Med       Date:  2013-07       Impact factor: 5.534

4.  Recent trends in the birth prevalence of Down syndrome in China: impact of prenatal diagnosis and subsequent terminations.

Authors:  Changfei Deng; Ling Yi; Yi Mu; Jun Zhu; Yanwen Qin; Xiaoxiao Fan; Yanping Wang; Qi Li; Li Dai
Journal:  Prenat Diagn       Date:  2015-02-16       Impact factor: 3.050

5.  Antenatal detection of hereditary disorders.

Authors:  H L Nadler
Journal:  Pediatrics       Date:  1968-12       Impact factor: 7.124

6.  First-trimester or second-trimester screening, or both, for Down's syndrome.

Authors:  Fergal D Malone; Jacob A Canick; Robert H Ball; David A Nyberg; Christine H Comstock; Radek Bukowski; Richard L Berkowitz; Susan J Gross; Lorraine Dugoff; Sabrina D Craigo; Ilan E Timor-Tritsch; Stephen R Carr; Honor M Wolfe; Kimberly Dukes; Diana W Bianchi; Alicja R Rudnicka; Allan K Hackshaw; Geralyn Lambert-Messerlian; Nicholas J Wald; Mary E D'Alton
Journal:  N Engl J Med       Date:  2005-11-10       Impact factor: 91.245

Review 7.  Millions of missing girls: from fetal sexing to high technology sex selection in India.

Authors:  Sabu M George
Journal:  Prenat Diagn       Date:  2006-07       Impact factor: 3.050

8.  Abortion patterns and reported sex ratios at birth in rural Yunnan, China.

Authors:  Petra Löfstedt; Luo Shusheng; Annika Johansson
Journal:  Reprod Health Matters       Date:  2004-11

9.  Screening for Down syndrome: changing practice of obstetricians.

Authors:  Deborah A Driscoll; Maria A Morgan; Jay Schulkin
Journal:  Am J Obstet Gynecol       Date:  2009-04       Impact factor: 8.661

10.  DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study.

Authors:  Glenn E Palomaki; Edward M Kloza; Geralyn M Lambert-Messerlian; James E Haddow; Louis M Neveux; Mathias Ehrich; Dirk van den Boom; Allan T Bombard; Cosmin Deciu; Wayne W Grody; Stanley F Nelson; Jacob A Canick
Journal:  Genet Med       Date:  2011-11       Impact factor: 8.822
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.